L.酸性/L.酸性/L.酸性/L.酸性 约翰逊比率影响老鼠缓慢过渡便秘
Yiqi Liao1,2, Yanfang Wang3, Weirui Huang1,2
1School of Pharmacy, Fujian Medical University, Fuzhou, 350122, China.
Scientific reports
|September 10, 2024
概括
乳杆菌酸性菌与乳杆菌约翰尼 (A/J) 的比率与缓慢过渡性便秘 (STC) 相对应. 调节这种比率可能为STC提供新的治疗策略.
科学领域:
- 胃肠病学 胃肠病学
- 微生物组研究 微生物组研究
- 代谢学 代谢学 代谢学
背景情况:
- 缓慢过渡性便秘 (STC) 是由结肠运动率降低来定义的.
- 肠道微生物群在STC病理生理学中的作用尚未完全理解.
- 特定的细菌比率,比如Lactobacillus acidophilus对Lactobacillus johnsonii (A/J),可能会影响肠道功能.
研究的目的:
- 在大鼠模型中研究A/J比率与STC发展之间的相关性.
- 探索抗生素和洛佩拉胺对A/J比率和STC的影响.
- 确定与STC相关的潜在微生物和代谢生物标志物.
主要方法:
- 使用了四个小鼠组:对照组 (CON),洛佩拉胺诱导的STC (LOP),抗生素治疗 (ABX) 和抗生素加洛佩拉胺 (ABX + LOP).
- 使用16S rRNA基因测序分析便样本以确定微生物组成.
- 通过液态染色体质谱法 (LC-MS) 检查血清代谢物.
主要成果:
- 洛普集团的A/J比率增加,与STC发展相关.
- 抗生素治疗 (ABX和ABX+LOP组) 降低了A/J比率,而ABX+LOP组没有出现STC症状.
- 在所有组中观察到血清代谢物的显著变化,包括瓜尼迪诺酸盐,甘氨酸,L-谷氨酸和其他物质.
结论:
- 在这种大鼠模型中,A/J比率与STC发展有很强的相关性.
- 抗生素诱导的A/J比率调节可以预防STC症状.
- 研究结果表明,肠道微生物组,特别是A/J比率,在STC中起着至关重要的作用,并为新疗法提供了潜在的点.
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
145
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
145
Drugs Affecting GI Tract Motility: Other Laxatives
173
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
173
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
189
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
189
Methods for Studying Drug Absorption: In situ
213
In situ experiments, such as the Doluisio method and Single-Pass Perfusion technique, provide critical insights into drug uptake by simulating in vivo conditions for drug absorption.
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
The Doluisio method involves perfusing a prepared segment of a rat's small intestine with a solution of radiolabeled drug and a non-absorbable marker. This helps to differentiate between absorbed and non-absorbed drug concentrations. The intestinal segment is connected at both ends using tubing and syringes,...
213
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
223
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
223
Drugs for Treatment of Diarrhea-Predominant IBS
153
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
153


